latest news releases from the newsroom
Habanero Resources Inc.
Habanero Announces New Alberta Oil and Gas Prospect Obtained and to Start Drilling Within Days
VANCOUVER, British Columbia, March 18, 2005 (PRIMEZONE) -- Habanero Resources Inc. ("HAO") (TSX-V:HAO) is extremely pleased to announce that it has entered into an agreement to participate in the Pembina Prospect, located on the Pembina Field in Alberta, Canada. HAO has secured at 10% working interest in this potential multi-well prospect. The initial well will be a re-entry and re-completion targeting the Viking Sands Formation. The operator expects the operations on this prospect to commence this weekend, with initial results expected within 7-10 days, barring any unforeseen issues.
Pergo Invitation to Annual General Meeting
STOCKHOLM, Sweden, March 18, 2005 (PRIMEZONE) -- The shareholders in Pergo AB (publ) are hereby invited to attend the Annual General Meeting on Monday 18 April 2005 at 3.00 PM at the Headquarters, Strandridaregatan 8, Trelleborg, Sweden.
Tele2 in Luxembourg Launches the First Worldwide Free TV for 3G Phones
NEW YORK and STOCKHOLM, Sweden, March 18, 2005 (PRIMEZONE) -- Tele2 AB ("Tele2") (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen: TEL2A and TEL2B), the leading alternative pan-European telecommunications company, today announced that it has launched the first worldwide free TV station available on 3G mobile phones, via its own TV channel Tango.TV (TTV).
Skandia Denmark Sharpens its Competitive Edge
STOCKHOLM, Sweden, March 18, 2005 (PRIMEZONE) -- Skandia is now beginning the work on creating a joint marketing organisation for the Danish market. The aim is to enable customers to access their entire portfolio of business with Skandia through a single phone call, visit to a website or contact person. Life assurance, unit linked assurance, banking services and healthcare insurance will be offered individually or in combination -- depending on the customer's needs.
Crucell Secures Exclusive Patent License from NIH to Commercialize Ebola Vaccines
LEIDEN, Netherlands, March 18, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has obtained an exclusive license to certain patents of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, to develop and commercialize recombinant vaccines against Ebola.
Boehringer Ingelheim and MorphoSys Enlarge Collaboration
MARTINSRIED, Germany, March 18, 2005 (PRIMEZONE) -- Boehringer Ingelheim and MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today an expansion of their existing cooperation involving both research and therapeutic applications. Under the new contract, Boehringer Ingelheim has acquired an option to receive several exclusive licenses on new therapeutic antibody programs. The two companies presently have two therapeutic antibody programs in joint collaboration. Additionally, Boehringer Ingelheim will obtain access to MorphoSys' HuCAL GOLD(r) library for research purposes at a number of the firm's research facilities. The first installation site is intended to be Boehringer Ingelheim's site in Vienna, Austria. MorphoSys will receive a technology access fee, annual license fees and optional R&D funding over the five-year collaboration term. For therapeutic antibodies emerging from the collaboration, Boehringer Ingelheim will pay milestone fees and royalties to MorphoSys. Financial details of the agreement were not disclosed.